Literature DB >> 17176633

Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).

Chung K Chu1, Srinivas Gadthula, Xin Chen, Hyunah Choo, Sureyya Olgen, Dale L Barnard, Robert W Sidwell.   

Abstract

The recent outbreak of severe acute respiratory syndrome (SARS), which is an acute respiratory illness, is caused by newly discovered SARS coronavirus (SARS-CoV). Herein we describe the antiviral activity of several classes of nucleoside analogues evaluated against SARS-CoV in Vero 76 cells, some of which exhibited moderate activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176633     DOI: 10.1177/095632020601700506

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  15 in total

Review 1.  The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing.

Authors:  E J Snijder; E Decroly; J Ziebuhr
Journal:  Adv Virus Res       Date:  2016-09-14       Impact factor: 9.937

2.  Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.

Authors:  Maria L Agostini; Erica L Andres; Amy C Sims; Rachel L Graham; Timothy P Sheahan; Xiaotao Lu; Everett Clinton Smith; James Brett Case; Joy Y Feng; Robert Jordan; Adrian S Ray; Tomas Cihlar; Dustin Siegel; Richard L Mackman; Michael O Clarke; Ralph S Baric; Mark R Denison
Journal:  mBio       Date:  2018-03-06       Impact factor: 7.867

3.  Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches.

Authors:  Depika Dwarka; Clement Agoni; John Jason Mellem; Mahmoud E Soliman; Himansu Baijnath
Journal:  S Afr J Bot       Date:  2020-08-19       Impact factor: 3.111

Review 4.  Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19.

Authors:  Keshav Rajarshi; Rajni Khan; Mrityunjay K Singh; Tushar Ranjan; Sandipan Ray; Shashikant Ray
Journal:  Gene       Date:  2020-11-18       Impact factor: 3.688

Review 5.  Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets.

Authors:  Didi Nurhadi Illian; Etti Sartina Siregar; Sumaiyah Sumaiyah; Ahmad Rusdan Utomo; Arif Nuryawan; Mohammad Basyuni
Journal:  Heliyon       Date:  2021-01-16

Review 6.  Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment.

Authors:  Yusuf Muhammed
Journal:  Biosaf Health       Date:  2020-07-09

Review 7.  Coronavirus Pandemic-Therapy and Vaccines.

Authors:  Kenneth Lundstrom
Journal:  Biomedicines       Date:  2020-05-03

Review 8.  SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets.

Authors:  Lorenzo Subissi; Isabelle Imbert; François Ferron; Axelle Collet; Bruno Coutard; Etienne Decroly; Bruno Canard
Journal:  Antiviral Res       Date:  2013-11-20       Impact factor: 5.970

9.  Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.

Authors:  Canrong Wu; Yang Liu; Yueying Yang; Peng Zhang; Wu Zhong; Yali Wang; Qiqi Wang; Yang Xu; Mingxue Li; Xingzhou Li; Mengzhu Zheng; Lixia Chen; Hua Li
Journal:  Acta Pharm Sin B       Date:  2020-02-27       Impact factor: 11.413

Review 10.  Structural and functional insights into non-structural proteins of coronaviruses.

Authors:  Mohammed A Rohaim; Rania F El Naggar; Emily Clayton; Muhammad Munir
Journal:  Microb Pathog       Date:  2020-11-23       Impact factor: 3.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.